glp 1 anxiety Most GLP-1 Medications Correlated with a Lower Likelihood of and Depression Diagnoses GLP-1s And Women's Brains: Addiction,
Description
6 Summary and outlook Metformin has been used globally for more than 60 years as the drug of choice for the treatment of T2DM

J Clin Endocrinol Metab 37: 826828, 1973

Its kidney benefits are secondary to its cardiovascular profile

Anyone with a BMI of 30 or above, or 27 with at least one weight-related comorbidity, meets the standard prescribing criteria for GLP-1 therapy

Obesity in Pregnancy: Practice Bulletin No
Given the relatively smaller reduction in body weight (9.4%) in the SELECT trial compared to previous RCTs: 14.9% in STEP1 (BMI 37.86.7 kg/m 2 ) [16] and 13.2% STEP6 (BMI 31.9 kg/m 2 ) [49], pleiotropic effects of semaglutide may contribute to the overall CV risk reduction [25,37]
